Nucleic acid testing (NAT) is the method of choice for detection and quantification of a wide range of micro organisms. Primerdesign manufactures and supplies high quality quantitative real-time PCR kits for the detection and simultaneous quantification of numerous significant pathogens. A copy number standard curve is provided for quantification and the internal extraction template (DNA or RNA), controls for the quality of the nucleic acid extraction and eliminates false negative results. The kit is designed with the broadest possible detection profile to ensure that all clinically relevant strains and subtypes are detected. Target sequences are selected by working with data from key opinion leaders in the field. Multiple sequence alignments and unprecedented real-time PCR expertise in design and validation ensure the best possible kit.

Acinetobacter baumannii is a Gram-negative bacterium of the Moraxellaceae family. The genome of this bacterium is around 4Mbp in length, arranged in a single, circular chromosome. The bacterium usually resides in soil or water but increasingly is found in nosocomial infections where antibiotic resistance is increasing. Porins in the outer cell membrane of the bacterium are greatly reduced in size compared to other Gram-negative species and contribute to increased antibiotic resistance.

A. baumannii has been found to be the cause of up to 10% of Gram-negative bacterial infections in Europe and the US. Individuals with weakened immune systems are particularly susceptible to infection by this species. Due to the ability of the bacterium to proliferate on many surfaces and environments including dry and static surfaces, nosocomial infections may occur by patient contact with hospital equipment, especially invasive apparatus where the bacterium can easily be introduced into the blood stream. A. baumanni infections are known to be involved in respiratory and urinary tract infections as well as causing pneumonia, septicaemia and meningitis.

The Primerdesign genesig Kit for Acinetobacter baumannii (A.baumannii) genomes is designed for the in vitro quantification of A.baumannii genomes. The kit is designed to have a broad detection profile. Specifically, the primers represent 100% homology with over 95% of the NCBI database reference sequences available at the time of design.

• Exceptional value for money
• Rapid detection of all clinically relevant subtypes
• Positive copy number standard curve for quantification
• Highly specific detection profile
• High priming efficiency
• Broad dynamic detection range (>6 logs)
• Sensitive to 100 copies of target
• Accurate controls to confirm findings
• genesig® kits are sold for research use only and are not licensed for diagnostic procedures
• Easy kit contents: target primer/probe mix; lyophilised oasig MasterMix; lyophilised oasig MasterMix resuspension buffer; positive control template; internal extraction control DNA/RNA; water; 54x genesig q16 reaction tubes
• Standard kit contents: primer and probe mix (150 reactions); reverse transcription, target specific primers (RNA genome viruses only); copy number standard curve (sufficient for multiple standard curves); RNAse/DNAse free water
• Advanced kit contents: primer and probe mix (150 reactions); reverse transcription, target specific primers (RNA genome viruses only); copy number standard curve (sufficient for multiple standard curves); internal extraction control - read through VIC channel (150 tests); endogenous control (150 tests); RNAse/DNAse free water